Status:
COMPLETED
Single Rising Dose Study (Intravenous Infusion and Subcutaneous Injection) of BI 655064 in Healthy Male Volunteers
Lead Sponsor:
Boehringer Ingelheim
Conditions:
Healthy
Eligibility:
MALE
18-55 years
Phase:
PHASE1
Brief Summary
To investigate safety and tolerability of BI 655064 in healthy male volunteers following intravenous infusion of escalating single doses and following subcutaneous injection. Exploration of the pharma...
Eligibility Criteria
Inclusion
- Inclusion criteria:
- 1\. Healthy male subjects
- Exclusion criteria:
- 1\. Any relevant deviation from healthy conditions
Exclusion
Key Trial Info
Start Date :
January 1 2012
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
September 1 2012
Estimated Enrollment :
72 Patients enrolled
Trial Details
Trial ID
NCT01510782
Start Date
January 1 2012
End Date
September 1 2012
Last Update
November 1 2013
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
1293.1.1 Boehringer Ingelheim Investigational Site
Berlin, Germany